Biochemical Engineering


Future Targeted Healthcare Manufacturing Hub

Biomanufacturing solutions to transform healthcare precision in the biotherapeutics sector

UCL Biochemical Engineering has an outstanding track record and is a world leader in bioprocess research across a range of sectors. UCL’s Future Targeted Healthcare Manufacturing Hub engages leading academics across the UK as Spokes.  This national asset is valued in excess of £20M over 7 years (2017–2024).

The Hub will address the manufacturing, business and regulatory challenges to ensure that new targeted biological medicines can be developed quickly and manufactured at a cost affordable to society.

Male and female scientists at bench in lab

The research will span stratified protein medicines targeted to particular patient groups through to truly personalised cell-based medicines.

The Hub is unique in the biomanufacturing space, and is being supported by a large number of the leading manufacturers and suppliers in the biotherapeutics industry and non-governmental associations.

How can stratified proteins and personal cell therapies achieve success in manufacturing and business?

Hub: Targeted Manufacturing Diagram

Further information


For more information on the Hub, collaboration and how join the industrial consortium please contact: 

HUB Logos 3 by 2 900x